Latest news
Loading news…
Leibniz Institute for Immunotherapy
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Regensburg, Bayern, Germany Founded 2010 51-100 employees For Profit
Leibniz Institute for Immunotherapy is an educational organization that offers research in target structures, cell production, and therapy.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
14
Patents
0
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 9
- Patents granted
- 0
- Trademarks
- 1
- IT spend
- $155K
Company Info
- Founded
- 2010
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 3
- HQ
- Regensburg, Bayern, Germany
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.1
- Trend (90d)
- -0.5
14
professional contacts at Leibniz Institute for Immunotherapy
Contact execs at Leibniz Institute for Immunotherapy →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Leibniz Institute for Immunotherapy
Loading news…
FAQs about Leibniz Institute for Immunotherapy
People who checked this page also checked these
Browse the full Acquirezy directory.